TOPLINE:  Among patients with rheumatoid arthritis (RA), a decrease in disease activity was noted with the use of biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs); […]

TOPLINE: The likelihood of developing inflammatory arthritis among patients with inflammatory bowel disease (IBD) peaks in the 6 months before the diagnosis of IBD and then […]

TOPLINE: Emapalumab, an anti-interferon gamma antibody that has effectively managed macrophage activation syndrome (MAS) in patients with Still’s disease, also controlled MAS in patients with systemic […]

TOPLINE: An individual patient data meta-analysis of two randomized trials involving treatment-naive patients with early rheumatoid arthritis (RA) found that a hand-dominant joint involvement pattern was […]

TOPLINE: Patients with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) had an increased risk for all-cause mortality compared with the general population, with a higher risk […]

TOPLINE: There is substantial variability in therapeutic drug monitoring (TDM) use among North American pediatric rheumatology providers largely due to inadequate training and data. METHODOLOGY: Researchers […]

TOPLINE: Combined definitions for the MRI of sacroiliac joint (MRI-SIJ) lesions proposed by Leiden and the Assessment of Spondyloarthritis International Society (ASAS)-MRI study group demonstrated a […]

TOPLINE: Patients with rheumatoid arthritis (RA) using abatacept who received the recombinant zoster vaccine (RZV) showed poor immune responses — both humoral and cellular — 4 […]